DIVALENT METAL-IONS INDUCE CONFORMATIONAL CHANGE IN PURE, HUMAN WILD-TYPE P53 TUMOR-SUPPRESSOR PROTEIN

被引:19
作者
COFFER, AI
KNOWLES, PP
机构
[1] Protein Isolation and Cloning Laboratory, The Imperial Cancer Research Fund, London, WC2A 3PX
来源
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY | 1994年 / 1209卷 / 02期
关键词
P53; SUPPRESSOR; PROTEIN CONFORMATION; METAL ION; (HUMAN);
D O I
10.1016/0167-4838(94)90197-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ability of wild-type and not mutant p53 to exert antiproliferative effects on normal cells may be related to a difference in the conformational state of the protein. We have used pure, human wild-type p53 and a panel of monoclonal antibodies whose epitopes map throughout the protein to assess whether divalent metal ions affect the conformation of p53. Our results show that the presence of Zn2+ ions at physiological concentrations, directly reduced or blocked accessibility of epitopes on pure wild-type p53, an effect which was reversed by chelating agents. Loss of epitope reactivity was maximal between the protein mid-region and C-terminus. Analytical sucrose density gradient ultracentrifugation studies also confirmed that Zn2+-induced conformational changes partially affected the pattern of p53 oligomerisation. The observed binding of pure p53 to a sequence-specific DNA motif was unaffected by the presence of added Zn2+ ions or metal chelating agents.
引用
收藏
页码:279 / 285
页数:7
相关论文
共 28 条
[1]   ISOLATION OF HUMAN-P53-SPECIFIC MONOCLONAL-ANTIBODIES AND THEIR USE IN THE STUDIES OF HUMAN P53 EXPRESSION [J].
BANKS, L ;
MATLASHEWSKI, G ;
CRAWFORD, L .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1986, 159 (03) :529-534
[2]   BIOCHEMICAL-CHARACTERIZATION OF PURIFIED HUMAN WILD-TYPE P53 OVEREXPRESSED IN INSECT CELLS [J].
CHALKLEY, GE ;
KNOWLES, PP ;
WHITEHEAD, PC ;
COFFER, AI .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 221 (01) :167-175
[3]   PURIFICATION OF COMPLEXES OF NUCLEAR ONCOGENE-P53 WITH RAT AND ESCHERICHIA-COLI HEAT-SHOCK PROTEINS - INVITRO DISSOCIATION OF HSC70 AND DNAK FROM MURINE-P53 BY ATP [J].
CLARKE, CF ;
CHENG, K ;
FREY, AB ;
STEIN, R ;
HINDS, PW ;
LEVINE, AJ .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (03) :1206-1215
[4]   PURIFICATION AND CHARACTERIZATION OF BIOLOGICALLY-ACTIVE SCATTER FACTOR FROM RAS-TRANSFORMED NIH 3T3 CONDITIONED MEDIUM [J].
COFFER, A ;
FELLOWS, J ;
YOUNG, S ;
PAPPIN, D ;
RAHMAN, D .
BIOCHEMICAL JOURNAL, 1991, 278 :35-41
[5]   THE TUMOR-SUPPRESSOR P53 [J].
DONEHOWER, LA ;
BRADLEY, A .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1155 (02) :181-205
[6]   DEFINITION OF A CONSENSUS BINDING-SITE FOR P53 [J].
ELDEIRY, WS ;
KERN, SE ;
PIETENPOL, JA ;
KINZLER, KW ;
VOGELSTEIN, B .
NATURE GENETICS, 1992, 1 (01) :45-49
[7]   ACTIVATING MUTATIONS IN P53 PRODUCE A COMMON CONFORMATIONAL EFFECT - A MONOCLONAL-ANTIBODY SPECIFIC FOR THE MUTANT FORM [J].
GANNON, JV ;
GREAVES, R ;
IGGO, R ;
LANE, DP .
EMBO JOURNAL, 1990, 9 (05) :1595-1602
[8]   MONOCLONAL-ANTIBODIES AGAINST SIMIAN VIRUS-40 T-ANTIGENS - EVIDENCE FOR DISTINCT SUBCLASSES OF LARGE T-ANTIGEN AND FOR SIMILARITIES AMONG NON-VIRAL T-ANTIGENS [J].
GURNEY, EG ;
HARRISON, RO ;
FENNO, J .
JOURNAL OF VIROLOGY, 1980, 34 (03) :752-763
[9]  
HAINAUT P, 1993, CANCER RES, V53, P1739
[10]  
HAINAUT P, 1993, CANCER RES, V53, P446